Sale of 14,144 shares at $35.42 per share.
Reporting Person Venker Eric · Officer Title President & Immunovant CEO · Transaction Code S
Traded Oct 20, 2026 · Disclosed Oct 22, 2026
Source: SEC Form 4 · 0001635088-26-000116 · filed 2026-10-22 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Roivant Sciences Ltd. (ROIV)." Disclosed 2026-10-22. https://desqlong.com/cards/0001635088-26-000116-2 (retrieved 2026-10-23).